🚀 VC round data is live in beta, check it out!
- Public Comps
- Agilent
Agilent Valuation Multiples
Discover revenue and EBITDA valuation multiples for Agilent and similar public comparables like GE HealthCare, ResMed, Waters, Natera and more.
Agilent Overview
About Agilent
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Founded
1999
HQ

Employees
18.1K
Website
Financials (LTM)
EV
$36B
Agilent Financials
Agilent reported last 12-month revenue of $7B and EBITDA of $2B.
In the same LTM period, Agilent generated $4B in gross profit, $2B in EBITDA, and $2B in net income.
Revenue (LTM)
Agilent P&L
In the most recent fiscal year, Agilent reported revenue of $7B and EBITDA of $2B.
Agilent expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 26% | XXX | XXX | XXX |
| Net Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Agilent Stock Performance
Agilent has current market cap of $34B, and enterprise value of $36B.
Market Cap Evolution
Agilent's stock price is $121.87.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36B | $34B | 3.1% | XXX | XXX | XXX | $5.63 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAgilent Valuation Multiples
Agilent trades at 5.1x EV/Revenue multiple, and 17.4x EV/EBITDA.
EV / Revenue (LTM)
Agilent Financial Valuation Multiples
As of April 18, 2026, Agilent has market cap of $34B and EV of $36B.
Equity research analysts estimate Agilent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Agilent has a P/E ratio of 21.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $34B | XXX | $34B | XXX | XXX | XXX |
| EV (current) | $36B | XXX | $36B | XXX | XXX | XXX |
| EV/Revenue | 5.1x | XXX | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 17.4x | XXX | 18.0x | XXX | XXX | XXX |
| EV/EBIT | 19.4x | XXX | 20.3x | XXX | XXX | XXX |
| EV/Gross Profit | 9.5x | XXX | 9.9x | XXX | XXX | XXX |
| P/E | 21.0x | XXX | 21.6x | XXX | XXX | XXX |
| EV/FCF | 31.1x | XXX | 30.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Agilent Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Agilent Margins & Growth Rates
Agilent's revenue in the last 12 month grew by 7%.
Agilent's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Agilent's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Agilent's rule of X is 45% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Agilent Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 45% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Agilent Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Agilent | XXX | XXX | XXX | XXX | XXX | XXX |
| GE HealthCare | XXX | XXX | XXX | XXX | XXX | XXX |
| ResMed | XXX | XXX | XXX | XXX | XXX | XXX |
| Waters | XXX | XXX | XXX | XXX | XXX | XXX |
| Natera | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcon | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Agilent M&A Activity
Agilent acquired XXX companies to date.
Last acquisition by Agilent was on XXXXXXXX, XXXXX. Agilent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Agilent
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAgilent Investment Activity
Agilent invested in XXX companies to date.
Agilent made its latest investment on XXXXXXXX, XXXXX. Agilent invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Agilent
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Agilent
| When was Agilent founded? | Agilent was founded in 1999. |
| Where is Agilent headquartered? | Agilent is headquartered in United States. |
| How many employees does Agilent have? | As of today, Agilent has over 18K employees. |
| Who is the CEO of Agilent? | Agilent's CEO is Padraig McDonnell. |
| Is Agilent publicly listed? | Yes, Agilent is a public company listed on NYSE. |
| What is the stock symbol of Agilent? | Agilent trades under A ticker. |
| When did Agilent go public? | Agilent went public in 1999. |
| Who are competitors of Agilent? | Agilent main competitors are GE HealthCare, ResMed, Waters, Natera. |
| What is the current market cap of Agilent? | Agilent's current market cap is $34B. |
| What is the current revenue of Agilent? | Agilent's last 12 months revenue is $7B. |
| What is the current revenue growth of Agilent? | Agilent revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Agilent? | Current revenue multiple of Agilent is 5.1x. |
| Is Agilent profitable? | Yes, Agilent is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Agilent? | Agilent's last 12 months EBITDA is $2B. |
| What is Agilent's EBITDA margin? | Agilent's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Agilent? | Current EBITDA multiple of Agilent is 17.4x. |
| What is the current FCF of Agilent? | Agilent's last 12 months FCF is $1B. |
| What is Agilent's FCF margin? | Agilent's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of Agilent? | Current FCF multiple of Agilent is 31.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.